Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bleomycin and brain tumors. A review.

R A Morantz, B F Kimler, T S Vats

    Journal of Neuro-Oncology
    |January 1, 1983
    PubMed
    Summary

    Directly injecting Bleomycin into brain tumors improved survival in rats compared to intravenous doses. Combining intracerebral Bleomycin with radiation or systemic BCNU showed enhanced efficacy for malignant brain tumors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Extracellular signal-regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity.

    Lupus·2008
    Same author

    Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells.

    Lupus·2007
    Same author

    Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma.

    Histopathology·2006
    Same author

    Breast-tissue sampling for risk assessment and prevention.

    Endocrine-related cancer·2005
    Same author

    Chemoprevention for high-risk women: tamoxifen and beyond.

    The breast journal·2002
    Same author

    Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.

    Annals of the New York Academy of Sciences·2002

    Area of Science:

    • Oncology
    • Neurosurgery
    • Pharmacology

    Background:

    • Malignant brain tumors exhibit cellular heterogeneity, necessitating combination therapies.
    • Systemic Bleomycin has limited efficacy due to poor blood-brain-barrier penetration and high toxicity.
    • Intracerebral drug delivery offers a potential solution for localized treatment.

    Purpose of the Study:

    • To evaluate the efficacy and safety of intracerebral Bleomycin administration for malignant brain tumors.
    • To assess the synergistic effects of intracerebral Bleomycin with radiation therapy and systemic chemotherapy.

    Main Methods:

    • Experimental study in rats with 9L gliosarcomas comparing intravenous and intracerebral Bleomycin doses.
    • Combination therapy studies involving intracerebral Bleomycin with radiation and systemic BCNU (carmustine).
    • Phase I clinical trial administering Bleomycin via an Ommaya reservoir in patients with recurrent brain tumors.

    Main Results:

    • Intracerebral Bleomycin significantly prolonged survival in rats compared to a 25-fold higher intravenous dose.
    • Combination of intracerebral Bleomycin with radiation therapy demonstrated superior outcomes than monotherapy.
    • Combined intracerebral Bleomycin and systemic BCNU proved more effective than individual treatments.
    • Phase I trial showed acceptable toxicity for intracerebral Bleomycin up to 7.5 units per dose and 255 units cumulative.

    Conclusions:

    • Intracerebral Bleomycin is a promising strategy for localized treatment of malignant brain tumors.
    • Combination therapy with intracerebral Bleomycin offers enhanced efficacy.
    • Intracerebral Bleomycin administration via an Ommaya reservoir is safe and feasible in patients with recurrent brain tumors.

    Related Experiment Videos